ASPIRION Celiac Disease Clinical Trial

The ASPIRION study is looking into a new, investigational study drug (amlitelimab) for patients with celiac disease. You may be eligible to participate if you:

    • Are 18 years or older
    • Have a confirmed diagnosis of celiac disease
    • Are still experiencing symptoms, despite following a gluten-free diet for at least 12 months

To be directed to the study website for more information, please enter your information below.  

Your privacy is important to us. Your information is confidential and will not be shared with any third parties. 

"*" indicates required fields

Name*
Privacy Policy and Terms of Use*